Your browser doesn't support javascript.
loading
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study.
Gandara, David R; von Pawel, Joachim; Mazieres, Julien; Sullivan, Richard; Helland, Åslaug; Han, Ji-Youn; Ponce Aix, Santiago; Rittmeyer, Achim; Barlesi, Fabrice; Kubo, Toshio; Park, Keunchil; Goldschmidt, Jerome; Gandhi, Mayank; Yun, Cindy; Yu, Wei; Matheny, Christina; He, Pei; Sandler, Alan; Ballinger, Marcus; Fehrenbacher, Louis.
Affiliation
  • Gandara DR; UC Davis Comprehensive Cancer Center, Sacramento, California. Electronic address: drgandara@ucdavis.edu.
  • von Pawel J; Asklepios-Fachkliniken München-Gauting, Gauting, Germany.
  • Mazieres J; Toulouse University Hospital, Toulouse, France.
  • Sullivan R; Auckland City Hospital, Auckland, New Zealand.
  • Helland Å; Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Han JY; National Cancer Center, Ilsandong-gu, Goyang, Korea.
  • Ponce Aix S; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Rittmeyer A; Lungenfachklinik Immenhausen, Immenhausen, Germany.
  • Barlesi F; Aix Marseille University; Assistance Publique Hôpitaux de Marseille, Marseille, France.
  • Kubo T; Okayama University Hospital, Okayama, Japan.
  • Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Korea.
  • Goldschmidt J; Blue Ridge Cancer Care, Blacksburg, Virginia; US Oncology Research, The Woodlands, Texas.
  • Gandhi M; Genentech, Inc., South San Francisco, California.
  • Yun C; Genentech, Inc., South San Francisco, California.
  • Yu W; Genentech, Inc., South San Francisco, California.
  • Matheny C; Genentech, Inc., South San Francisco, California.
  • He P; Blue Ridge Cancer Care, Blacksburg, Virginia; US Oncology Research, The Woodlands, Texas; Genentech, Inc., South San Francisco, California.
  • Sandler A; Genentech, Inc., South San Francisco, California.
  • Ballinger M; Genentech, Inc., South San Francisco, California.
  • Fehrenbacher L; Kaiser Permanente Medical Center, Vallejo, California.
J Thorac Oncol ; 13(12): 1906-1918, 2018 12.
Article in En | MEDLINE | ID: mdl-30217492
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Salvage Therapy / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2018 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Salvage Therapy / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Thorac Oncol Year: 2018 Document type: Article Country of publication: United States